Schisandrin B Protects Against Acute Ethanol-Induced Cardiac Injury by Downregulating Autophagy Via the NOX4/ROS Pathway.

Youli Tao,Hua Zhou,Lili Huang,Xiaoyin Xu,Yun Huang,Lili Ma,Lingna Li,Xu Yao,Ronghui Zhang,Yuyu Zhang,Weibo Rong,Chaojun Yang,Taotao Yang,Yi Shen,Rixiang Wang
DOI: https://doi.org/10.1159/000510863
IF: 3.4293
2021-01-01
Pharmacology
Abstract:INTRODUCTION:Although oxidative stress has been demonstrated to mediate acute ethanol-induced changes in autophagy in the heart, the precise mechanism behind redox regulation in acute ethanol heart disease remains largely unknown.METHODS:Wild-type C57BL/6 mice were intraperitoneally injected with ethanol (3 g/kg/day) for 3 consecutive days. The effects of ethanol on cultured primary cardiomyocytes and H9c2 myoblasts were also studied in vitro. Levels of autophagic flux, cardiac apoptosis and function, reactive oxygen species (ROS) accumulation, NOX4, and NOX2 were examined. The NOX4 gene was knocked down with NOX4 siRNA.RESULTS:In this study, we demonstrated that schisandrin B inhibited acute ethanol-induced autophagy and sequent apoptosis. In addition, schisandrin B treatment improved cardiac function in ethanol-treated mice. Furthermore, NOX4 protein expression was increased during acute ethanol exposure, and the upregulation of NOX4 was significantly inhibited by schisandrin B treatment. The knockdown of NOX4 prevented ROS accumulation, cell autophagy, and apoptosis.CONCLUSION:These results highlight that NOX4 is a critical mediator of ROS and elaborate the role of the NOX4/ROS axis in the effect of schisandrin B on autophagy and autophagy-mediated apoptosis in acute ethanol exposure, which suggests a therapeutic strategy for acute alcoholic cardiomyopathy.
What problem does this paper attempt to address?